These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Synthesis, Characterization, Antimicrobial Activity and Anticancer of Some New Pyrazolo[1,5-a]pyrimidines and Pyrazolo[5,1-c]1,2,4-triazines. Hosny MA; Zaki YH; Mokbel WA; Abdelhamid AO Med Chem; 2020; 16(6):750-760. PubMed ID: 31218963 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, pharmacological screening and computational analysis of some 2-(1H-Indol-3-yl)-N'-[(un)substituted phenylmethylidene] acetohydrazides and 2-(1H-Indol-3-yl)-N'-[(un)substituted benzoyl/2-thienylcarbonyl]acetohydrazides. Rubab K; Abbasi MA; Rehman A; Siddiqui SZ; Shah SAA; Ashraf M; Ain Q; Ahmad I; Lodhi MA; Ghufran M; Shahid M; Fatima H Pak J Pharm Sci; 2017 Jul; 30(4):1263-1274. PubMed ID: 29039324 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological evaluation, and in silico studies of indole-tethered pyrazoline derivatives as anticancer agents targeting topoisomerase IIα. Haider K; Sharma S; Pokharel YR; Das S; Joseph A; Najmi AK; Ahmad F; Yar MS Drug Dev Res; 2022 Nov; 83(7):1555-1577. PubMed ID: 35898169 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, Biological Evaluation, and 3D-QSAR Studies of Wu Z; Park HY; Xie D; Yang J; Hou S; Shahzad N; Kim CK; Yang S J Agric Food Chem; 2021 Feb; 69(4):1214-1223. PubMed ID: 33480684 [TBL] [Abstract][Full Text] [Related]
7. Graph Theoretical analysis, in silico modeling and molecular dynamic studies of (5-((2-chloropyridin-4-yl)oxy)-3-phenyl-1H-pyrazol-1-yl)-2-(4-substituted phenyl)-N,N-dimethylethen-1-amine derivatives for the treatment of breast cancer. Panneerselvam T; Kunjiappan S; Govindaraj S; Gopal M; Natarajan K; Hegde YM; Shanmugam N; Srinivas G; Ravi K; Natarajan V Anticancer Agents Med Chem; 2022 Dec; ():. PubMed ID: 36475343 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of purine-pyrazole hybrids incorporating thiazole, thiazolidinone or rhodanine moiety as 15-LOX inhibitors endowed with anticancer and antioxidant potential. Afifi OS; Shaaban OG; Abd El Razik HA; Shams El-Dine SEA; Ashour FA; El-Tombary AA; Abu-Serie MM Bioorg Chem; 2019 Jun; 87():821-837. PubMed ID: 30999135 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of Novel Pyridine Bearing Biologically Active Imidiazolyl, Pyrazolyl, Oxa/thiadiazolyl and Urea Derivatives as Promising Anticancer Agents. Hafez HN; El-Gazzar ABA Curr Org Synth; 2020; 17(1):55-64. PubMed ID: 32103718 [TBL] [Abstract][Full Text] [Related]
10. Design, green synthesis, molecular docking and anticancer evaluations of diazepam bearing sulfonamide moieties as VEGFR-2 inhibitors. Saleh NM; El-Gaby MSA; El-Adl K; Abd El-Sattar NEA Bioorg Chem; 2020 Nov; 104():104350. PubMed ID: 33142416 [TBL] [Abstract][Full Text] [Related]
11. Discovery of New Schiff Bases Tethered Pyrazole Moiety: Design, Synthesis, Biological Evaluation, and Molecular Docking Study as Dual Targeting DHFR/DNA Gyrase Inhibitors with Immunomodulatory Activity. Hassan AS; Askar AA; Naglah AM; Almehizia AA; Ragab A Molecules; 2020 Jun; 25(11):. PubMed ID: 32498469 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and potential biological activity of some novel 3-[(N-substituted indol-3-yl)methyleneamino]-6-amino-4-aryl-pyrano(2,3-c)pyrazole-5-carbonitriles and 3,6-diamino-4-(N-substituted indol-3-yl)pyrano(2,3-c)pyrazole-5-carbonitriles. Mandour AH; El-Sawy ER; Ebaid MS; Hassan SM Acta Pharm; 2012 Mar; 62(1):15-30. PubMed ID: 22472446 [TBL] [Abstract][Full Text] [Related]
13. Anticancer activity of newly synthesized 1,1-disubstituted cyclohexane-1-carboxamides: in vitro caspases mediated apoptosis activators in human cancer cell lines and their molecular modeling. Abd-Allah WH; Salman A; Sabry Saad S Drug Dev Res; 2019 Nov; 80(7):933-947. PubMed ID: 31343754 [TBL] [Abstract][Full Text] [Related]
14. Antiproliferative evaluations of triazoloquinazolines as classical DNA intercalators: Design, synthesis, ADMET profile, and molecular docking. Eissa IH; Ibrahim MK; Alesawy MS; El-Adl K Arch Pharm (Weinheim); 2022 May; 355(5):e2100487. PubMed ID: 35194810 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, anticancer effect and molecular modeling of new thiazolylpyrazolyl coumarin derivatives targeting VEGFR-2 kinase and inducing cell cycle arrest and apoptosis. Mohamed TK; Batran RZ; Elseginy SA; Ali MM; Mahmoud AE Bioorg Chem; 2019 Apr; 85():253-273. PubMed ID: 30641320 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, molecular docking and biological activity evaluation of some novel indole derivatives as potent anticancer active agents and apoptosis inducers. El-Sharief AMS; Ammar YA; Belal A; El-Sharief MAMS; Mohamed YA; Mehany ABM; Elhag Ali GAM; Ragab A Bioorg Chem; 2019 Apr; 85():399-412. PubMed ID: 30665034 [TBL] [Abstract][Full Text] [Related]
17. New series of fused pyrazolopyridines: Synthesis, molecular modeling, antimicrobial, antiquorum-sensing and antitumor activities. El-Gohary NS; Hawas SS; Gabr MT; Shaaban MI; El-Ashmawy MB Bioorg Chem; 2019 Nov; 92():103109. PubMed ID: 31521987 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, Anticancer Activity on Prostate Cancer Cell Lines and Molecular Modeling Studies of Flurbiprofen-Thioether Derivatives as Potential Target of MetAP (Type II). Yılmaz Ö; Bayer B; Bekçi H; Uba AI; Cumaoğlu A; Yelekçi K; Küçükgüzel ŞG Med Chem; 2020; 16(6):735-749. PubMed ID: 31203805 [TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis and Evaluation of Novel (E)-N'-((1-(4-chlorobenzyl)-1H-indol-3-yl)methylene)-2-(4-oxoquinazolin-3(4H)-yl)acetohydrazides as Antitumor Agents. Dung DTM; Park EJ; Anh DT; Hai PT; Bao LQ; Ji AY; Kang JS; Tung TT; Han SB; Nam NH Anticancer Agents Med Chem; 2022; 22(14):2586-2598. PubMed ID: 35040418 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, antitumour activities and molecular docking of thiocarboxylic acid ester-based NSAID scaffolds: COX-2 inhibition and mechanistic studies. El-Azab AS; Abdel-Aziz AA; Abou-Zeid LA; El-Husseiny WM; El Morsy AM; El-Gendy MA; El-Sayed MA J Enzyme Inhib Med Chem; 2018 Dec; 33(1):989-998. PubMed ID: 29806488 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]